Microbial exopolysaccharide-based nano-carriers with unique multi-functionalities for biomedical sectors
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Herein, we have presented a broad overview of microbial exopolysaccharide (EPS)-based nano-structures that are continuously being explored for their potential biomedical applications, e.g., cell and/or drug encapsulation, gene delivery, tissue engineering, diagnostics, and related therapeutics. The sustainable exploitation of naturally occurring EPS-based polymeric nano-carriers using state-of-the-art nanotech engineering approaches has provided an excellent alternative to conventional bioimaging and drug delivery technologies. EPS-based drug transport covers a specific niche “intelligent therapeutics” which is still being established and has not been well described in the literature. Thus, herein, an effort has been made to cover this literature gap to present unique multi-functional potentialities of microbial EPS with suitable examples. EPS-based nano-pharmaceutics exhibit certain advantages over conventional counterparts, such as ease in preparation, in vivo biocompatibility, biodegradability, and sustainability. EPS and their derivatives are successfully applied for several biomedical applications, e.g., wound dressing scaffolds, arthritis treatment, dental impressions, and tissue engineering purposes. The progress in targeted delivery systems using micro and nanosystems has opened a new dimension in biopolymer-based biomedicines and smart surgical procedures. This huge area of biomedical engineering is described by the availability of a diverse range of EPS-derivatives, whose multi-functional characteristics can be controlled. Through bioconjugation, i.e., functionalized composite production, different systems have been designed, such as controlled drug release and target accumulation of therapeutic substances. Potential EPS applications are not just limited to targeted transport but also covers several emerging diagnostic technologies. Several bioactive EPS have also been studied for their properties like anti-viral, anti-bacterial, anti-tumor and immunomodulatory activities. Based on currently available data on EPS-based nano-structures for biomedical domains, it can be undoubtedly stated that they present a broad future ahead.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kamoun, E. A., Kenawy, E.-R. S., & Chen, X. (2017) · Journal of Advanced Research · doi:10.1016/j.jare.2017.01.005 · Cited by 1,707
Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications
Qiao, R., Yang, C., & Gao, M. (2009) · Journal of Materials Chemistry · doi:10.1039/b902394a · Cited by 685
Wang, K., Li, W., Rui, X., Chen, X., Jiang, M., & Dong, M. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.10.036 · Cited by 325
Dilna, S. V., Surya, H., Aswathy, R. G., Varsha, K. K., Sakthikumar, D. N., Pandey, A., & Nampoothiri, K. M. (2015) · LWT - Food Science and Technology · doi:10.1016/j.lwt.2015.07.040 · Cited by 262
Asgher, M., Urooj, Y., Qamar, S. A., & Khalid, N. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.11.094 · Cited by 121
Self-citationAsgher, M., Arshad, S., Qamar, S. A., & Khalid, N. (2020) · SN Applied Sciences · doi:10.1007/s42452-020-2783-3 · Cited by 93
Self-citation
Cited by
Advances in Microbial Exopolysaccharides: Present and Future Applications
Nguyen, H.-T., Pham, T.-T., Nguyen, P.-T., Le-Buanec, H., Rabetafika, H. N., & Razafindralambo, H. L. (2024) · Biomolecules · doi:10.3390/biom14091162 · Cited by 101
Gulati, S., Ansari, N., Moriya, Y., Joshi, K., Prasad, D., Sajwan, G., Shukla, S., Kumar, S., & Varma, R. S. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00599f · Cited by 52
Alginate-based bio-nanohybrids with unique properties for biomedical applications
Qamar, S., Karim, S., Aslam, S., Jahangeer, M., Nelofer, R., Nadeem, A. A., Qamar, S. A., Jesionowski, T., & Bilal, M. (2024) · Starch - Stärke · doi:10.1002/star.202200100 · Cited by 46
Self-citationAsgher, M., Rani, A., Khalid, N., Qamar, S. A., & Bilal, M. (2021) · Case Studies in Chemical and Environmental Engineering · doi:10.1016/j.cscee.2021.100084 · Cited by 35
Self-citationAyub, A., Rahayu, F., Khamidah, A., Antarlina, S. S., Iswari, K., Supriyadi, K., Mufidah, E., Singh, A., Chopra, C., & Wani, A. K. (2025) · Discover Applied Sciences · doi:10.1007/s42452-025-06916-3 · Cited by 29
“Research has indicated that EPS can be used in the development of pharmaceutical agents targeting inflammatory and immune-related diseases [80, 81].”
Metadata
- Authors
- Asgher, M., Qamar, S. A., & Iqbal, H. M. N.
- Venue
- Biologia
- Published
- 2020-09-07
- Volume
- 76
- Issue
- 2
- Pages
- 673-685
- ISSN
- 0006-3088 (ISSN-L)
- 1336-9563
- OpenAlex
- W3082996228
- Cited by
- 52
- References
- 6
- FWCI
- 3.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Microbial exopolysaccharide-based nano-carriers with unique multi-functionalities for biomedical sectors. https://app.cochat.ai/papers/10.2478/s11756-020-00588-7
- The paper
- Asgher, M., Qamar, S. A., & Iqbal, H. M. N. (2021). Microbial exopolysaccharide-based nano-carriers with unique multi-functionalities for biomedical sectors. Biologia. https://doi.org/10.2478/s11756-020-00588-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.